PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZODASIRAN IN ADOLESCENT AND ADULT SUBJECTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (YOSEMITE)
- Registry ID
- AROANG3-3001
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- ARROWHEAD PHARMACEUTICALS, INC.
- Start date
- 2026-03-23
- Last update
- 2025-10-08
Conditions
- FAMILIAL HYPERCHOLESTEROLEMIA
Related clinical trials
- AN OPEN-LABEL, SINGLE ARM, MULTICENTER EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF INCLISIRAN IN PARTICIPANTS WITH HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WHO HAVE COMPLETED THE PEDIATRIC ORION-16, ORION-13, ORION-20, OR ORION-19 STUDIES (VICTORION-PEDS-OLE)
- A PLACEBO-CONTROLLED, DOSE-ESCALATION STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SINGLE AND MULTIPLE DOSES OF ISIS 703802, TARGETING ANGPTL3, ADMINISTERED SUBCUTANEOUSLY TO HEALTHY VOLUNTEERS WITH ELEVATED TRIGLYCERIDES AND SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
View on source registry